Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
Open Access
- 1 June 2020
- journal article
- research article
- Published by Springer Nature in Oncogenesis
- Vol. 9 (6) , 1-12
Abstract
Peritoneal dissemination is a particular form of metastasis typically observed in ovarian cancer and the major cause for poor patient’s outcome. Identification of the molecular players involved in ovarian cancer dissemination can offer an approach to develop treatment strategies to improve clinical prognosis. Here, we identified mesothelin (MSLN) as a crucial protein in the multistep process of peritoneal dissemination of ovarian cancer. We demonstrated that MSLN is overexpressed in primary and matched peritoneal metastasis of high-grade serous carcinomas (HGSC). Using several genetically engineered ovarian cancer cell lines, resulting in loss or gain of function, we found that MSLN increased cell survival in suspension and invasion of tumor cells through the mesothelial cell layer in vitro. Intraperitoneal xenografts established with MSLNhigh ovarian cancer cell lines showed enhanced tumor burden and spread within the peritoneal cavity. These findings provide strong evidences that MSLN is a key player in ovarian cancer progression by triggering peritoneal dissemination and provide support for further clinical investigation of MSLN as a therapeutic target in HGSC.Keywords
This publication has 58 references indexed in Scilit:
- Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 ActivationScientific Reports, 2013
- Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancerBritish Journal of Cancer, 2012
- Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric ReceptorMolecular Therapy, 2012
- Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the MesotheliumCancer Discovery, 2011
- Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferationCarcinogenesis, 2011
- Anchorage-independent cell growth signature identifies tumors with metastatic potentialOncogene, 2009
- The biology of ovarian cancer: new opportunities for translationNature Reviews Cancer, 2009
- High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinomaBritish Journal of Cancer, 2009
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domainsProceedings of the National Academy of Sciences, 2009
- A Binding Domain on Mesothelin for CA125/MUC16Journal of Biological Chemistry, 2009